Long-term autonomy, professional activities, cognition, and overall survival after awake functional-based surgery in patients with IDH-mutant grade 2 gliomas: a retrospective cohort study

IF 13.6 Q1 HEALTH CARE SCIENCES & SERVICES
Sam Ng , Valérie Rigau , Sylvie Moritz-Gasser , Catherine Gozé , Amélie Darlix , Guillaume Herbet , Hugues Duffau
{"title":"Long-term autonomy, professional activities, cognition, and overall survival after awake functional-based surgery in patients with IDH-mutant grade 2 gliomas: a retrospective cohort study","authors":"Sam Ng ,&nbsp;Valérie Rigau ,&nbsp;Sylvie Moritz-Gasser ,&nbsp;Catherine Gozé ,&nbsp;Amélie Darlix ,&nbsp;Guillaume Herbet ,&nbsp;Hugues Duffau","doi":"10.1016/j.lanepe.2024.101078","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>In isocitrate dehydrogenase (IDH)-mutant low-grade gliomas (LGGs), awake functional-based resection (i.e., resection based on intraoperative functional responses rather than anatomical margins) has emerged as an efficient method to reduce tumour volume (TV) while minimizing postoperative deficits. Here, our goal was to assess the long-term onco-functional outcomes after awake functional-based resection in IDH-mutant LGGs, in conjunction with clinico-radiological and molecular factors.</div></div><div><h3>Methods</h3><div>We retrospectively studied a consecutive cohort (June 1997–January 2023) of 949 patients. Six hundred patients with IDH-mutant LGGs benefited from an awake functional-based resection with a median follow-up of 7.8 years (95% Confidence interval [CI]: 7.1–8.4 years). The main outcomes were the overall survival (OS), the OS with Karnofsky performance status ≥80% (OS<sub>KPS</sub><sub>≥</sub><sub>80%</sub>), cognition measures, and professional activities at 12 months post-surgery.</div></div><div><h3>Findings</h3><div>600 patients were included in the cohort (274 female [46.0%], median age: 36 years [Interquartile range, IQR: 30–44 years]). The rate of return to work was 93.7%. The impact of surgery on cognition was of limited magnitude. The median postsurgical TV of 2.5 mL (IQR: 0–8.0 mL). The median OS was over 20 years (median: NA, 95% CI: 17.0-NA years). The median OS<sub>KPS</sub><sub>≥</sub><sub>80%</sub> was 14.7 years (95% CI: 13.2–17.2 years). Factors associated with longer OS and OS<sub>KPS</sub><sub>≥</sub><sub>P80%</sub> were 1p19q codeletion (Hazard ratio [HR]<sub>OS</sub>: 0.27, 95% CI: 0.16–0.43, HR<sub>KPS</sub><sub>≥</sub><sub>80%</sub>:0.25, 95% CI: 0.17–0.36), supratotal resection (HR<sub>OS</sub>: 0.08, 95% CI: 0.005–0.40, HR<sub>KPS</sub><sub>≥</sub><sub>80%</sub>:0.12, 95% CI: 0.03–0.34) and total resection (HR<sub>OS</sub>: 0.31, 95% CI: 0.16–0.59, HR<sub>KPS</sub><sub>≥</sub><sub>80%</sub>:0.21, 95% CI: 0.12–0.36). Recursive partitioning analyses established three OS and OS<sub>KPS</sub><sub>≥</sub><sub>80%</sub> prognostic groups, highlighting the contributions of histomolecular status, extent of resection, postsurgical and presurgical TV. Further propensity-matching analyses confirmed the oncological benefits of supratotal resections.</div></div><div><h3>Interpretation</h3><div>Awake functional-based resection surgery in newly diagnosed IDH-mutant grade 2 LGG, was an effective strategy associated with long survival (median OS over 20 years) and long-term preservation of autonomy. More complete tumor resections favored better onco-functional outcomes across all molecularly-defined subtypes. Short-term effects were of limited magnitude regarding postoperative cognitive and professional outcomes. Supratotal functional-based resections offered additional survival benefits.</div></div><div><h3>Funding</h3><div>None.</div></div>","PeriodicalId":53223,"journal":{"name":"Lancet Regional Health-Europe","volume":"46 ","pages":"Article 101078"},"PeriodicalIF":13.6000,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266677622400245X/pdfft?md5=3cc60a9f54c016f5c76446211986140d&pid=1-s2.0-S266677622400245X-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Regional Health-Europe","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266677622400245X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

In isocitrate dehydrogenase (IDH)-mutant low-grade gliomas (LGGs), awake functional-based resection (i.e., resection based on intraoperative functional responses rather than anatomical margins) has emerged as an efficient method to reduce tumour volume (TV) while minimizing postoperative deficits. Here, our goal was to assess the long-term onco-functional outcomes after awake functional-based resection in IDH-mutant LGGs, in conjunction with clinico-radiological and molecular factors.

Methods

We retrospectively studied a consecutive cohort (June 1997–January 2023) of 949 patients. Six hundred patients with IDH-mutant LGGs benefited from an awake functional-based resection with a median follow-up of 7.8 years (95% Confidence interval [CI]: 7.1–8.4 years). The main outcomes were the overall survival (OS), the OS with Karnofsky performance status ≥80% (OSKPS80%), cognition measures, and professional activities at 12 months post-surgery.

Findings

600 patients were included in the cohort (274 female [46.0%], median age: 36 years [Interquartile range, IQR: 30–44 years]). The rate of return to work was 93.7%. The impact of surgery on cognition was of limited magnitude. The median postsurgical TV of 2.5 mL (IQR: 0–8.0 mL). The median OS was over 20 years (median: NA, 95% CI: 17.0-NA years). The median OSKPS80% was 14.7 years (95% CI: 13.2–17.2 years). Factors associated with longer OS and OSKPSP80% were 1p19q codeletion (Hazard ratio [HR]OS: 0.27, 95% CI: 0.16–0.43, HRKPS80%:0.25, 95% CI: 0.17–0.36), supratotal resection (HROS: 0.08, 95% CI: 0.005–0.40, HRKPS80%:0.12, 95% CI: 0.03–0.34) and total resection (HROS: 0.31, 95% CI: 0.16–0.59, HRKPS80%:0.21, 95% CI: 0.12–0.36). Recursive partitioning analyses established three OS and OSKPS80% prognostic groups, highlighting the contributions of histomolecular status, extent of resection, postsurgical and presurgical TV. Further propensity-matching analyses confirmed the oncological benefits of supratotal resections.

Interpretation

Awake functional-based resection surgery in newly diagnosed IDH-mutant grade 2 LGG, was an effective strategy associated with long survival (median OS over 20 years) and long-term preservation of autonomy. More complete tumor resections favored better onco-functional outcomes across all molecularly-defined subtypes. Short-term effects were of limited magnitude regarding postoperative cognitive and professional outcomes. Supratotal functional-based resections offered additional survival benefits.

Funding

None.
IDH突变2级胶质瘤患者清醒功能性手术后的长期自主性、职业活动、认知能力和总生存率:一项回顾性队列研究
背景在异柠檬酸脱氢酶(IDH)突变的低级别胶质瘤(LGG)中,基于清醒功能的切除术(即基于术中功能反应而非解剖学边缘的切除术)已成为一种有效的方法,可在减少肿瘤体积(TV)的同时最大限度地减少术后功能障碍。在此,我们的目标是结合临床放射学和分子因素,评估 IDH 突变 LGG 基于清醒功能性切除术后的长期功能性结果。600名IDH突变LGG患者接受了基于功能的清醒切除术,中位随访时间为7.8年(95% 置信区间[CI]:7.1-8.4年)。主要结果包括总生存期(OS)、Karnofsky表现状态≥80%时的OS(OSKPS≥80%)、认知指标以及术后12个月的职业活动。重返工作岗位的比例为 93.7%。手术对认知能力的影响程度有限。手术后TV的中位数为2.5毫升(IQR:0-8.0毫升)。中位OS超过20年(中位数:NA,95% CI:17.0-NA年)。OSKPS≥80%的中位数为14.7年(95% CI:13.2-17.2年)。与更长的OS和OSKPS≥P80%相关的因素是1p19q编码缺失(危险比[HR]OS:0.27,95% CI:0.16-0.43,HRKPS≥80%:0.25,95% CI:0.17-0.36)、超全切除(HROS:0.08,95% CI:0.005-0.40,HRKPS≥80%:0.12,95% CI:0.03-0.34)和全切除(HROS:0.31,95% CI:0.16-0.59,HRKPS≥80%:0.21,95% CI:0.12-0.36)。递归分区分析建立了三个OS和OSKPS≥80%预后组,强调了组织分子状态、切除范围、手术后和手术前电视的贡献。进一步的倾向匹配分析证实了超全切的肿瘤学益处。释义对于新诊断的IDH突变2级LGG,基于功能的清醒切除手术是一种有效的策略,可获得较长的生存期(中位OS超过20年)并长期保留自主权。在所有分子定义的亚型中,更彻底的肿瘤切除有利于获得更好的肿瘤功能性结果。在术后认知和职业结果方面,短期效果有限。基于功能的超全切可带来额外的生存益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
19.90
自引率
1.40%
发文量
260
审稿时长
9 weeks
期刊介绍: The Lancet Regional Health – Europe, a gold open access journal, is part of The Lancet's global effort to promote healthcare quality and accessibility worldwide. It focuses on advancing clinical practice and health policy in the European region to enhance health outcomes. The journal publishes high-quality original research advocating changes in clinical practice and health policy. It also includes reviews, commentaries, and opinion pieces on regional health topics, such as infection and disease prevention, healthy aging, and reducing health disparities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信